“We delivered outstanding performance in the second quarter, reflecting the strength of our proven growth strategy, our team’s excellent execution and the power of our PPI Business System,” said Marc N. Casper, chairman and ... Read more
The recent Bundibugyo Ebola virus outbreak underscored the limitations of relying solely on highly targeted diagnostics, highlighting the need for more adaptable approaches to infectious disease surveillance. In this interview with BioPharma BoardRoo... Read more
In H1 2026, Lonza1 delivered sales of CHF 3.4 billion with +16.0% CER2 sales growth The CORE EBITDA margin significantly expanded by +4.4ppts versus H1 2025, reaching 34.8% with a CORE EBITDA of CHF 1.2 billion Free Cash Flow (FCF)... Read more
Danaher Corporation announced results for the second quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted. Key Second Quarter 2026 Results ... Read more
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced that the Biomedical Advanced Research and Develop... Read more
Senior secured term loan of up to CHF 250 million with a 5‑year maturity at a fixed 7% interest rate First tranche will fully refinance the existing New Money Facility, maturing in May 2027 Eliminates near‑term debt maturities and strengthens b... Read more
Reached a long-term business cooperation with a large pharmaceutical company to help it promote production licensing and commercial supervision and approval in major markets. Customers choose AGC Biologics Yokohama's new base to promote five com... Read more
Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at CHF 44.31 per share, representing an equity value of approxim... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
